In KEGG terms, we observed that the B-cell receptor signaling pathway and hematopoietic cell lineage were down-regulated in C2, while the IL-17 signaling pathway, gastric cancer, and basal cell carcinoma were up-regulated in C2. The gene discussed is IL17A; the disease is basal cell carcinoma.